50-12-103. Availability of experimental drugs. (1) A manufacturer of an investigational drug, biological product, or device may make the drug, product, or device available to a patient who has requested the drug, product, or device pursuant to this part.

(2) The manufacturer may:

(a) provide an investigational drug, biological product, or device to a patient without receiving compensation; or

(b) require a patient to pay the costs of or the costs associated with the manufacture of the investigational drug, biological product, or device.

(3) A manufacturer is not required to make an investigational drug, biological product, or device available to a patient.